A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites
- PMID: 3800908
- PMCID: PMC1147041
- DOI: 10.1042/bj2370655
A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites
Abstract
Extraction of control human spleen glucocerebrosidase with sodium cholate and butan-l-ol reversibly inactivates the enzyme in terms of its ability to hydrolyse the water-soluble substrate 4-methylumbelliferyl beta-D-glucopyranoside (MUGlc). The acidic brain lipid galactocerebroside 3-sulphate (sulphatide) reconstitutes beta-glucosidase activity in a strongly concentration-dependent manner. In this study we show that sulphatide exhibits three critical micellar concentrations (CMCs): CMC1, 3.72 microM; CMC2, 22.6 microM; CMC3, 60.7 microM. We designate the aggregates formed at these CMCs as primary, secondary and tertiary micelles respectively. From the results of kinetic studies performed at various sulphatide concentrations (0.012-248 microM), we found that sulphatide monomers (less than 3 microM) decreased the Km (for MUGlc) of control glucocerebrosidase from 11 to 4.6 mM, and lowered the Vmax. 2-fold. However, secondary and tertiary micelles were required for expression of high control glucocerebrosidase activities. Glucocerebrosidase prepared from the spleen of a patient with non-neuronopathic type 1 Gaucher's disease exhibited a very low Km (2.8 mM) even in the absence of exogenous lipid, and sulphatide monomers had no effect on the mutant enzyme's Km or Vmax. However, secondary or tertiary micelles markedly increased the Vmax. of the type 1 glucocerebrosidase to 60% of the corresponding control enzyme value. In contrast, for the glucocerebrosidase of the neuronopathic type 2 case, although sulphatide decreased the Km from 9.2 to 1.7 mM, the Vmax. never reached more than 5% that of the control enzyme, even at high concentrations of sulphatide. In addition, we found that secondary and tertiary sulphatide micelles enhanced the rate of inactivation of all three glucocerebrosidase preparations by chymotrypsin. Collectively, these results indicate the presence of two sulphatide-binding sites on glucocerebrosidase: one that enhances substrate binding, and another that enhances catalysis.
Similar articles
-
Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.Clin Chim Acta. 1986 Apr 30;156(2):179-89. doi: 10.1016/0009-8981(86)90151-8. Clin Chim Acta. 1986. PMID: 3085988
-
Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.Arch Biochem Biophys. 1988 Apr;262(1):345-53. doi: 10.1016/0003-9861(88)90197-x. Arch Biochem Biophys. 1988. PMID: 3355173
-
Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.J Biol Chem. 1984 Feb 10;259(3):1714-9. J Biol Chem. 1984. PMID: 6693432
-
Mammalian glucocerebrosidase: implications for Gaucher's disease.Lab Invest. 1988 Jan;58(1):5-25. Lab Invest. 1988. PMID: 3275832 Review. No abstract available.
-
[Beta-glucosidases. Molecular bases of Gaucher's disease].Pathol Biol (Paris). 1985 Jun;33(6):693-713. Pathol Biol (Paris). 1985. PMID: 3931039 Review. French.
Cited by
-
Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.Biochem J. 1995 Sep 1;310 ( Pt 2)(Pt 2):571-5. doi: 10.1042/bj3100571. Biochem J. 1995. PMID: 7654196 Free PMC article.
-
Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.Biochem J. 1988 Aug 15;254(1):77-84. doi: 10.1042/bj2540077. Biochem J. 1988. PMID: 3178760 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources